Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 160.8 SEK -1.65% Market Closed
Market Cap: 12.8B SEK
Have any thoughts about
Biotage AB?
Write Note

Biotage AB
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biotage AB
Income from Continuing Operations Peer Comparison

Comparables:
ALIF B
BICO
G
GENO
MCAP
M
MAGLE

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Biotage AB
STO:BIOT
Income from Continuing Operations
kr257m
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
17%
AddLife AB
STO:ALIF B
Income from Continuing Operations
kr192m
CAGR 3-Years
-28%
CAGR 5-Years
8%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Income from Continuing Operations
-kr1.7B
CAGR 3-Years
-226%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genovis AB
STO:GENO
Income from Continuing Operations
kr17.3m
CAGR 3-Years
14%
CAGR 5-Years
30%
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Income from Continuing Operations
kr229m
CAGR 3-Years
43%
CAGR 5-Years
38%
CAGR 10-Years
29%
M
Magle Chemoswed Holding AB
STO:MAGLE
Income from Continuing Operations
kr12.2m
CAGR 3-Years
89%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Biotage AB's Income from Continuing Operations?
Income from Continuing Operations
257m SEK

Based on the financial report for Sep 30, 2024, Biotage AB's Income from Continuing Operations amounts to 257m SEK.

What is Biotage AB's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
17%

Over the last year, the Income from Continuing Operations growth was 36%. The average annual Income from Continuing Operations growth rates for Biotage AB have been 8% over the past three years , 6% over the past five years , and 17% over the past ten years .

Back to Top